CVB homepage TrendingFirst US patient implanted with Biotronik leadless pacemakerSeven-second X-ray assesses severity of regurgitation congenital heart defect patientsThe key to AI cardiology analytics is human actionU.S. Supreme Court sides with generic drug maker for severe hypertriglyceridemia agent icosapent ethylAI detection of cardiac amyloidosis on ECG granted patentExploring the pros and cons of direct-to-patient drug programsThese programs may provide benefits in some cases. In others, however, there is a concern that they could actually lead to higher costs over time.PAD patients minimize risk when they listen to their doctorsPatients who exercise and take all prescribed medications, for instance, experience better outcomes than those who do not.ACC-AHA release first cardiovascular-kidney-metabolic syndrome guidelinesScience shows the deep relationship between cardiac, kidney and metabolism issues that may impact up to 90% of the U.S. population. BioCardia raises $4.4 million in financing for its heart failure cell therapiesFunds with help bring its cellular therapeutics to market in the next year.New guideline standardizes echo guidance for mitral transcatheter edge-to-edge repairsThe new guideline emphasizes the importance of 3D multiplanar reconstruction for M-TEER to increase precision.Star Trek star's family awarded $13M in heart failure malpractice caseNichelle Nichols, who played Lt. Uhura in Star Trek, died from undiagnosed and untreated heart failure after seeking medical treatment.Longest-distance robotic cardiac telesurgery ever performed over 12,500 milesA left internal mammary artery takedown robot-assisted heart procedure is the latest milestone for an Indian robotics company.First US patient implanted with Biotronik leadless pacemakerThe LivIQ leadless pacemaker offers a single-device solution designed to deliver AV synchrony through far-field sensing. Seven-second X-ray assesses severity of regurgitation congenital heart defect patientsMoving X-ray images can help evaluate pulmonary regurgitation in Tetralogy of Fallot patients. Load MoreInnovation at workCardiovascular Business Fewer biopsies, happier patients: Why molecular blood testing is a game-changer for managing heart transplant recipientsFollow-up care after a successful heart transplant can be challenging—both for providers and their patients. Consider, for example, the fact that so many patients who develop complications never actually present with symptoms. In cooperation with CareDxAround the webRadiology Business Radiologists tout support for bipartisan bill to address interventional ‘payment crisis’Radiology Business US congressman helps secure $750,000 for rural hospital’s radiology expansionRadiology Business RadNet secures $250M new loan, gets downgrade from Moody’s
